Drug's effects on embryonic blood-vessel growth may be the source of malformed limbs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Therapontos, C., Erskine, L., Gardner, E. R., Figg, W. D. & Vargesson, N. Proc. Natl Acad. Sci. USA doi:10.1073/pnas.0901505106 (2009).
Knobloch, J., Shaughnessy, J. D. Jr & Ruther, U. FASEB J. 21, 1410–1421 (2007).
Related links
Related links
Related links in Nature Research
Nature Reviews Cancer Focus on Targeting Angiogenesis
Related external links
National Toxicology Program: Thalidomide
Rights and permissions
About this article
Cite this article
Ledford, H. How thalidomide makes its mark. Nature (2009). https://doi.org/10.1038/news.2009.462
Published:
DOI: https://doi.org/10.1038/news.2009.462
